ArticleESMO open2024

Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.

A T Meuleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.